These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30099941)

  • 1. Incidence of cardiovascular risk factors in female patients with systemic lupus erythematosus: a 3-year follow-up cohort.
    Monção CSA; Martins LN; Penteado MPS; Reis RCP; Santos FMM; Lanna CCD; Ribeiro AL; Telles RW
    Lupus; 2018 Oct; 27(11):1790-1798. PubMed ID: 30099941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics.
    Telles R; Lanna C; Ferreira G; Ribeiro A
    Lupus; 2010 Jun; 19(7):803-9. PubMed ID: 20118159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
    Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
    Medeiros MM; Xavier de Oliveira ÍM; Ribeiro ÁT
    Rheumatol Int; 2016 Jan; 36(1):117-24. PubMed ID: 26149124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for coronary artery disease in patients with systemic lupus erythematosus.
    Petri M; Perez-Gutthann S; Spence D; Hochberg MC
    Am J Med; 1992 Nov; 93(5):513-9. PubMed ID: 1442853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
    Hinojosa-Azaola A; Romero-Diaz J; Vargas-Ruiz AG; Nuñez-Alvarez CA; Cicero-Casarrubias A; Ocampo-Torres MC; Sanchez-Guerrero J
    J Rheumatol; 2016 Mar; 43(3):576-86. PubMed ID: 26773122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials.
    Muniz LF; Pereira RMR; Silva TF; Bonfá E; Borba EF
    Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1255-1262. PubMed ID: 25832035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
    PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus risk factors for coronary artery calcifications.
    Romero-Díaz J; Vargas-Vóracková F; Kimura-Hayama E; Cortázar-Benítez LF; Gijón-Mitre R; Criales S; Cabiedes-Contreras J; Iñiguez-Rodríguez Mdel R; Lara-García EA; Núñez-Alvarez C; Llorente L; Aguilar-Salinas C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2012 Jan; 51(1):110-9. PubMed ID: 22039268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices.
    Petri M; Spence D; Bone LR; Hochberg MC
    Medicine (Baltimore); 1992 Sep; 71(5):291-302. PubMed ID: 1522805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting.
    Telles RW; Lanna CC; Ferreira GA; Souza AJ; Navarro TP; Ribeiro AL
    Lupus; 2008 Feb; 17(2):105-13. PubMed ID: 18250133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in patients with systemic lupus erythematosus: Association with disease activity, disease damage and age.
    Mobini M; Niksolat F; Mohammadpour RA; Dashti Dargahloo S; Marzban D
    Int J Rheum Dis; 2018 May; 21(5):1023-1030. PubMed ID: 29611288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences of cardiovascular risk factors in patients with symptomatic carotid disease.
    Maksimović M; Vlajinac H; Radak D; Marinković J; Maksimović J; Jorga J
    Srp Arh Celok Lek; 2013; 141(11-12):758-63. PubMed ID: 24502093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
    Urowitz MB; Ibañez D; Su J; Gladman DD
    J Rheumatol; 2016 May; 43(5):875-9. PubMed ID: 26879352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyslipidaemia and atherogenic risk in patients with systemic lupus erythematosus].
    Batún Garrido JA; Radillo Alba HA; Hernández Núñez É; Olán F
    Med Clin (Barc); 2016 Jul; 147(2):63-6. PubMed ID: 27197885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.